SVFoenix
SVFoenix
Mesenchymal stem cell (MSC) therapy is one of the most innovative modern medical approaches for controlling and preventing graft-versus-host disease (GVHD) in cancer patients following bone marrow transplantation.
Product Specifications
- Reduced risk of graft-versus-host disease (GVHD):
By modulating the immune response and suppressing inflammation, it prevents severe immune reactions. - Anti-inflammatory and immune-modulating properties:
- Secretion of anti-inflammatory factors leads to a reduction in systemic inflammation.
- High safety profile with minimal side effects:
Unlike conventional immunosuppressive drugs, it has a targeted effect without broad suppression of the immune system. - Unlike conventional immunosuppressive drugs, it has a targeted effect without broad suppression of the immune system.
Unlike conventional immunosuppressive drugs, it has a targeted effect without broad suppression of the immune system.